REXAHN PHARMACEUTICALS, INC. Business Operations Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sales Agreement, dated January 13, 2025, between the Company and Leerink Partners LLC
Sales Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2025
License and Collaboration Agreement dated as of November 6, 2022 by and between Ocuphire Pharma, Inc. and Famy
Collaboration Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Placement Agency Agreement, dated as of June 4, 2021, by and between Ocuphire Pharma, Inc. and A.G.P./Alliance Global Partners
Agency Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Placement Agency Agreement, dated as of June 4, 2021, by and between Ocuphire Pharma, Inc. and A.G.P./Alliance Global Partners
Agency Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Capital on Demand Sales Agreement, dated March 11, 2021 between Ocuphire Pharma, Inc. and JonesTrading Institutional Services LLC
Sales Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2021
Form of Indemnification Agreement
Indemnification Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Form of Ocuphire Voting Agreement, by and among Ocuphire, Rexahn and certain stockholders of Ocuphire
Voting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Amendment No. 2 to Collaboration and License Agreement, dated as of March 10, 2020 between BioSense Global LLC and Rexahn Pharmaceuticals, Inc
Collaboration Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Amendment No. 1 to Collaboration and License Agreement
Collaboration Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Collaboration and License Agreement, dated as of February 25, 2019, between BioSense Global LLC and Rexahn Pharmaceuticals, Inc
Collaboration Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Clinical Trial Collaboration and Supply Agreement, dated August 13, 2018, by and between Merck Sharp & Dohme B.V., and Rexahn Pharmaceuticals, Inc
Collaboration Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2018
At Market Issuance Sales Agreement, dated March 16, 2015, by and between Rexahn Pharmaceuticals, Inc. and MLV & CO. LLC
Sales Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MD
2015
Financial Advisory Services Agreement, dated February 12, 2010, by and Between the Company and Garden State Securities Inc
Services Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2010
Form of Termination and Release Agreement dated May 17, 2010
Termination Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MD
2010